OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
The OncLive Insider app is live!CME Opportunities
Specialty
View MoreBreast CancerLung CancerGastrointestinal CancerGenitourinary CancersOvarian CancerProstate CancerMelanoma & Skin CancerMCLMPNCAR T-cell TherapyChronic Lymphocytic LeukemiaGynecologic OncologyHematologic OncologyImmuno-OncologyMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
PartnersPublications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker ConsortiumSubscribe
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2025 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • The OncLive Insider app is live!
  • CME Opportunities
SpecialtySee All >
  • Breast Cancer
  • Lung Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Ovarian Cancer
  • Prostate Cancer
  • Melanoma & Skin Cancer
  • MCL
  • MPN
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gynecologic Oncology
  • Hematologic Oncology
  • Immuno-Oncology
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Advances and Issues in NSCLC

EP. 1: Squamous Cell Carcinoma Treatment Options

February 13th 2013

EP. 2: Introduction: Advances and Issues in NSCLC

February 13th 2013

EP. 3: Best Practices in NSCLC Molecular Testing, Part I

February 13th 2013

EP. 4: Concurrent Versus Sequential Testing in NSCLC

February 13th 2013

EP. 5: Best Practices in NSCLC Molecular Testing, Part II

February 13th 2013

EP. 6: Molecular Testing and Actionable Targets in NSCLC

February 13th 2013

EP. 7: Rebiopsying and Molecular Testing in NSCLC

February 13th 2013

EP. 8: Selecting a Laboratory for Molecular Testing in NSCLC

February 13th 2013

EP. 9: Selecting Treatment for First- Line Non-Squamous NSCLC

February 13th 2013

EP. 10: Molecular Heterogeneity in Non-Small Cell Lung Cancer

February 13th 2013

EP. 11: Promising Emerging Classes of Therapies in NSCLC

February 13th 2013

EP. 12: Personalizing the Treatment of Lung Cancer

February 13th 2013

EP. 13: Access to Molecular Testing Therapy in NSCLC

February 13th 2013

EP. 14: Impact of EGFR Mutations on Treatment Decisions in NSCLC

February 13th 2013

EP. 15: The Cost-Effectiveness of Targeted Therapies in NSCLC

February 13th 2013